Clinical Trials Sponsored by The Caring Together Program
Total 0 results
Nothing found
Sponsors and Collaborators
- United States Department of Defense (DOD)
- Rivierduinen, Centre for Personality disorders Jelgersma
- Lilly PharmaceuticalCompany
- Foshan Sanshui District People's Hospital
- Plethora Solutions Ltd
- Arsha Vidya Tirtha
- Eurotrials Brasil Consultores Cientificos Ltda
- Oblikue Consulting
- Cardiovascular Center Dedinje, Belgrade, Serbia
- S-Biotek Holding ApS
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Gunkang Pharmaceuticals, Inc
- Paulo Sérgio Gomes Nogueira Borges
- Iyad Naeem Muhammad, PhD
- Sudimplant SAS - Groupe TBR
- University of Applied Sciences Jena
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Korea Otsuka International Asia Arab
- Julian Taylor Green
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- View Full List
Medical Conditions
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Testicular Teratoma
- Advance Directive Completion
- Gray Platelet Syndrome
- Huntington Chorea
- Serum Albumin Low
- Blepharospasm of Both Eyelids
- Puberty, Delayed
- Visual Attention Span Deficit
- Brain Tumor, Primary
- Immunologically-induced Lung Disease
- Chemotherapy-Induced Neutropenia
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Anemia Acute
- Hypothermia Following Anesthesia, Sequela
- Vibration; Exposure
- Thyroid and Parathyroid Surgery
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Malaria,Falciparum
- Deformity Flexion
- View Full List
Drug Interventions
- Bimatoprost 0.03% eye drops
- Furmonertinib 160 mg
- Ebselen
- Pegfilgrastim
- MMV390048 120mg
- Celecoxib
- Cytisine
- Vosaroxin
- Standard medical therapy
- Sorafenib
- F520
- Acalabrutinib in combination with VR
- S-Adenosyl-Methionine
- ABY-035 i.v.
- Cyanoacrylate
- Rovalpituzumab tesirine
- Pemetrexed
- Mineralocorticoid receptor antagonist
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Oxycodone
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Chile
- Contract Research Organizations in Congo
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in India
- Contract Research Organizations in Iran
- Contract Research Organizations in Italy
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Morocco
- Contract Research Organizations in Slovakia
- Contract Research Organizations in South Africa
- Contract Research Organizations in Uzbekistan
- CRO list by country